Niagen Bioscience
(NASDAQ) NAGE
Niagen Bioscience Financials at a Glance
Market Cap
$291.50M
Revenue (TTM)
$130.42M
Net Income (TTM)
$18.64M
EPS (TTM)
$0.22
P/E Ratio
16.77
Dividend
$0.00
Beta (Volatility)
1.51 (High)
Dividend
$0.00
Beta (Volatility)
1.51 (High)
Price
$3.67
Volume
30,290
Open
$3.81
Price
$3.67
Volume
30,290
Open
$3.81
Previous Close
$3.67
Daily Range
$3.67 - $3.82
52-Week Range
$3.56 - $14.69
Dividend
$0.00
Beta (Volatility)
1.51 (High)
Price
$3.67
Volume
30,290
Open
$3.81
Previous Close
$3.67
Daily Range
$3.67 - $3.82
52-Week Range
$3.56 - $14.69
NAGE News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Niagen Bioscience
Industry
Personal Products
Sector
Consumer StaplesEmployees
117
CEO
Robert N. Fried, MBA
Website
www.niagenbioscience.comHeadquarters
Los Angeles, CA 90024, US
NAGE Financials
Key Financial Metrics (TTM)
Gross Margin
64%
Operating Margin
9%
Net Income Margin
14%
Return on Equity
27%
Return on Capital
12%
Return on Assets
16%
Earnings Yield
5.96%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$291.50M
Shares Outstanding
79.64M
Volume
30.29K
Avg. Volume
1.21M
Financials (TTM)
Gross Profit
$83.19M
Operating Income
$14.30M
EBITDA
$15.75M
Operating Cash Flow
$13.44M
Capital Expenditure
$292.00K
Free Cash Flow
$13.14M
Cash & ST Invst.
$64.79M
Total Debt
$2.82M
Niagen Bioscience Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$31.47M
+3.3%
Gross Profit
$19.98M
+3.3%
Gross Margin
63.47%
N/A
Market Cap
$291.50M
N/A
Market Cap/Employee
$2.80M
N/A
Employees
104
N/A
Net Income
$6.32M
+24.8%
EBITDA
$1.87M
-63.7%
Quarterly Fundamentals
Net Cash
$63.97M
+23.2%
Accounts Receivable
$13.07M
+85.3%
Inventory
$24.02M
+114.7%
Long Term Debt
$1.54M
-40.1%
Short Term Debt
$1.03M
+8.9%
Return on Assets
16.30%
N/A
Return on Invested Capital
12.13%
N/A
Free Cash Flow
$1.25M
-116.0%
Operating Cash Flow
$1.19M
-115.1%